Oddo BHF downgraded Novo Nordisk (NVO) to Neutral from Outperform with a DKK 465 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Citi opens ‘upside catalyst watch’ on Eli Lilly post selloff
- Novo Nordisk downgraded to Equal Weight from Overweight at Barclays
- Novo Nordisk Stock (NVO) Plunges 20% on Guidance Cut and CEO Appointment
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Video: Why JPMorgan Is Defending Eli Lilly Today